Home Healthcare IT Global Cell and Gene Therapy Manufacturing QC Market Size And Share Report By 2028

Global Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028

Global Cell and Gene Therapy Manufacturing QC Market Size

According to Straits Research analysis, the Global Cell and Gene Therapy Manufacturing QC Market was valued at USD 2235.72 Million in 2024 and is projected to reach USD 5458.28 Million by 2028, expanding at a CAGR of 25.1% during the forecast period. This sharp rise is likely due to the growing use of these therapies in the medical and pharmaceutical sectors to cure genetic diseases and cancers. Advancements in gene-editing technologies like CRISPR, pave the way for more efficient and reliable testing procedures, fueling the market growth. The move towards green production and sustainability, with emphasis on low-carbon manufacturing, offers additional market opportunities. Export potential is steadily increasing with the globalization of health services and therapies. As advancements continue, regions are positioning themselves accordingly, for example, the Asia-Pacific region is expected to witness substantial growth due to increased investment in biomedical research.

Global Cell and Gene Therapy Manufacturing QC Market Highlights

  • By segment, Cell Therapy emerged as the largest Therapy Type in terms of market size in 2024.
  • Gene Therapy is anticipated to remain the most attractive Therapy Type segment, recording the fastest growth during the forecast period.
  • As of 2024, Global held % of the global cell and gene therapy manufacturing qc market size.
  • By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
  • In Global, North America is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
  • Asia Pacific will remain the fastest-growing market in Global, reaching USD 215275.32 Million by 2028.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2028
Historical Period 2021-2023
Forecast Period 2025-2028
Market Size In 2024 USD 2235.72 Million
Market Size In 2028 USD 5458.28 Million
Largest segment Cell Therapy
Fastest segment Gene Therapy
Units Revenue in USD Million
CAGR 25.1% (2025-2028)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Global Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type

Segmentation Covered

Segments Sub Segments
Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East And Africa
Therapy Type
  1. Cell Therapy
  2. Gene Therapy
Cell Therapy
  1. CAR-T
  2. CAR-NK
  3. B-Cell
  4. Other
CAR-T
  1. Autologous CAR-T
  2. Allogeneic CAR-T
Gene Therapy
  1. Viral
  2. Non-Viral
Viral
  1. AAV
  2. Lentiviral vectors
  3. Other
Scale
  1. Pre commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
Process
  1. Upstream Processes
  2. Downstream Processes
End User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
Pharmaceutical Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Biopharmaceutical / Biotechnological Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Contract Manufacturing Organizations
  1. Small Size
  2. Medium Size
  3. Large Size
Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others 

Cell and Gene Therapy Manufacturing QC Market- Geographics


WhatsApp
Chat with us on WhatsApp